[1]
“Comparison of gefitinib plus chemotherapy versus gefitinib alone for advanced non‑small‑cell lung cancer: A meta analysis”, Clinics, vol. 78, p. 100152, Jan. 2023, doi: 10.1016/j.clinsp.2022.100152.